AI in Healthcare: Can Intelligent Software Help Doctors Detect Disease Earlier?
Radiology dominates the AI medical devices cleared in the US, and India's TB programme already uses AI to read X-rays. Why validation and human doctors still decide.

A radiologist in a district hospital may review hundreds of chest X-rays a day. A small shadow on one of them can be easy to miss when tired. This is one of the places where artificial intelligence has shown its most practical value in medicine: not by replacing the doctor, but by acting as a tireless second pair of eyes.
Where AI is already in clinical use
Medical imaging is by far the most advanced area. In the United States, the Food and Drug Administration keeps a public list of AI-enabled medical devices it has authorised. According to analyses of that list at the end of 2025, more than 1,400 such devices had been authorised since 1995, and roughly three-quarters of them are for radiology: reading X-rays, CT and MRI scans, mammograms and similar images.
Typical uses include:
- highlighting suspicious areas on a scan for the radiologist to check;
- prioritising urgent cases, such as a suspected brain bleed, so they are read first;
- measuring organs or tumours automatically.
India's TB example
India has the world's largest burden of tuberculosis. The Indian Council of Medical Research developed an AI tool, DeepCxR, that sorts chest X-rays into normal and abnormal and flags findings such as possible TB. In March 2025 the health ministry told Parliament that the National TB Elimination Programme had adopted it and deployed it in eight states and union territories.

The workflow matters: the AI flags, then a person with an abnormal reading is tested with a sputum sample that is confirmed in a laboratory. In studies of screening in Delhi's settlements and among tribal communities in Chhattisgarh, AI-assisted X-rays were used to decide who should be tested, not to diagnose. Evaluations of the tools suggest they can be helpful for screening, though accuracy varies and some figures remain provisional.
Beyond scans
- Clinical decision support: software that reads a patient's records and warns about dangerous drug interactions or early signs of deterioration.
- Patient monitoring: algorithms analysing signals from wearables or hospital monitors to spot irregular heart rhythms.
- Drug discovery: AI that predicts protein structures and candidate molecules, shortening early research. (See how AI is changing scientific discovery.)
Why caution is essential
A tool that looks good in a company demonstration can perform worse in the real world. Hospitals differ in machines, patient populations and image quality, so clinical validation in the setting where it will be used is crucial. Other concerns:
- Bias: a system trained mostly on one population may be less accurate for others.
- Over-reliance: doctors may trust a wrong output, or ignore a correct one.
- Privacy: health data are among the most sensitive and need strong legal protection.
- Accountability: when an AI-assisted decision goes wrong, someone qualified must be responsible.
What this means for you
- AI findings are inputs for your doctor, not diagnoses. Be wary of apps that claim to diagnose from a photo or a symptom checklist.
- Ask where your data go and who can see them.
- If a hospital uses AI for screening, ask what happens next if it flags something, and what happens if it doesn't.
Used well, AI can help overstretched health systems find disease earlier. The goal is not a robot doctor, but better-supported human ones.
Sources
This article draws on the following reporting. Dates are when each source was originally published.
- US Food and Drug Administration: Artificial Intelligence-Enabled Medical Devices
- Applied Radiology: Radiology AI tools dominate latest FDA device approvals
- ICMR: Artificial Intelligence Tool for Screening of Pulmonary Tuberculosis (AI4CXR)
- NCBI / PubMed Central: Evaluating the Usefulness of AI-based Chest X-Ray Screening in Improving TB Detection Among the High-Risk Tribal Population of Chhattisgarh
- The Week (PTI): AI-driven tools used for TB screening under 100-day intensified campaign, Govt tells Rajya Sabha

Written by
Newsroom
Reporting, explainers and analysis from The Daily’s editorial desk, based on verified public sources that are listed with every story.
More from The Daily Desk →Enjoyed this story?
Get the best of The Daily in your inbox every Sunday.



